▶ 調査レポート

創傷洗浄システムの世界市場2022-2031:産業分析、規模、シェア、成長、動向、予測

• 英文タイトル:Wound Irrigation Systems Market (Product Type: Irrigation Fluids, Antiseptics, Topical Antibiotics, Wetting Agents, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2022-2031

Transparency Market Researchが調査・発行した産業分析レポートです。創傷洗浄システムの世界市場2022-2031:産業分析、規模、シェア、成長、動向、予測 / Wound Irrigation Systems Market (Product Type: Irrigation Fluids, Antiseptics, Topical Antibiotics, Wetting Agents, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2022-2031 / MRC2210A0065資料のイメージです。• レポートコード:MRC2210A0065
• 出版社/出版日:Transparency Market Research / 2022年7月
• レポート形態:英文、PDF、175ページ
• 納品方法:Eメール
• 産業分類:医療機器
• 販売価格(消費税別)
  Single User¥857,660 (USD5,795)▷ お問い合わせ
  Multi User¥1,301,660 (USD8,795)▷ お問い合わせ
  Corporate License¥1,745,660 (USD11,795)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
Transparency Market Research社の本調査レポートでは、世界の創傷洗浄システム市場規模について調査し、序論、仮定・調査手法、エグゼクティブサマリー、市場概要、主要洞察、傷種類別(火傷、糖尿病性足潰瘍、外科的創傷、外傷性創傷、その他)分析、エンドユーザー別(病院、外科手術センター、在宅治療、その他)分析、地域別(北米、ヨーロッパ、アジア太平洋、中南米、中東/アフリカ)分析、競争状況など、以下の項目を掲載しております。本書では、Stryker、B.Braun、Cardinal Health、Baxter、Zimmer Biomet、Becton,Dickinson and Company、Schulke、Bionix、Cooper Surgical、Sanara MedTech、Mölnlycke Health Care AB、Irrisept、Actimaris、Pulsecare medicalなどの企業情報が含まれています。
・序論
・仮定・調査手法
・エグゼクティブサマリー
・市場概要
・主要洞察

・世界の創傷洗浄システム市場規模:傷種類別
- 火傷用洗浄器の市場規模
- 糖尿病性足潰瘍用洗浄器の市場規模
- 外科的創傷用洗浄器の市場規模
- 外傷性創傷用洗浄器の市場規模
- その他傷種類の市場規模

・世界の創傷洗浄システム市場規模:エンドユーザー別
- 病院における市場規模
- 外科手術センターにおける市場規模
- 在宅治療における市場規模
- その他エンドユーザーの市場規模

・世界の創傷洗浄システム市場規模:地域別
- 北米の創傷洗浄システム市場規模
- ヨーロッパの創傷洗浄システム市場規模
- アジア太平洋の創傷洗浄システム市場規模
- 中南米の創傷洗浄システム市場規模
- 中東/アフリカの創傷洗浄システム市場規模

・競争状況

Wound Irrigation Systems Market – Scope of Report
TMR’s report on the global wound irrigation systems market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2022 to 2031. The report provides revenue of the global wound irrigation systems market for the period 2017–2031, considering 2021 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global wound irrigation systems market from 2022 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the wound irrigation systems market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global wound irrigation systems market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report sheds light on the changing competitive dynamics in the global wound irrigation systems market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global wound irrigation systems market.

The report delves into the competitive landscape of the global wound irrigation systems market. Key players operating in the global wound irrigation systems market have been identified and each one of these has been profiled, in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are attributes of players in the global wound irrigation systems market profiled in this report.

RESEARCH METHODOLOGY

The research methodology will be a combination of exhaustive primary and secondary research to analyze the market wound irrigation systems.

Secondary Research

Secondary research includes a search of company literature, technical writing, patent data, Internet sources, and statistical data from government websites, trade associations, and agencies. This has proven to be the most reliable, effective, and successful approach for obtaining precise data, capturing industry participants’ insights, and recognizing business opportunities.

Secondary research sources that we typically refer, but are not limited to:

Company websites, presentations, annual reports, white papers, technical paper, product brochure
Internal and external proprietary databases and relevant patents
National government documents, statistical databases, and market reports
News articles, press releases, and webcasts specific to companies operating in the market

Specific Secondary Sources:

Industry Sources:
WorldWideScience.org
Elsevier, Inc.
National Institutes of Health (NIH)
PubMed
NCBI
Department of Health Care Service
Trade Data Sources
Trade Map
UN Comtrade
Trade Atlas
Company Information
OneSource Business Browser
Hoover’s
Factiva
Bloomberg
Mergers & Acquisitions
Thomson Mergers & Acquisitions
MergerStat
Profound

Primary Research

During the course of research, we conduct in-depth interviews and discussions with a wide range of key industry participants and opinion leaders. Primary research represents bulk of research efforts, supplemented by extensive secondary research.

We conduct primary interviews on the ongoing basis with industry participants and commentators to validate data and analysis. A typical research interview fulfills the following functions:

Provides first-hand information on market size, market trends, growth trends, competitive landscape, outlook, etc.
Helps in validating and strengthening secondary research findings
Further develops the analysis team’s expertise and market understanding
Primary research involves e-mail interactions, telephonic interviews, as well as face-to-face interviews for each market, category, segment, and sub-segment across geographies

Participants who typically take part in such a process include, but are not limited to:

Industry participants: Marketing/product managers, market intelligence managers, and regional sales managers
Purchasing/Sourcing managers, technical personnel, distributors
Outside experts: Investment bankers, valuation experts, and research analysts specializing in specific markets
Key opinion leaders specializing in different areas corresponding to different industry verticals

List of primary participants, but not limited to:

Advanced Oncotherapy PLC
Danfysik A/S
Hitachi, Ltd.
IBA Worldwide
Mevion Medical Systems, Inc.

Data Triangulation: Information culled from “Secondary & Primary Sources” is cross-checked with “TMR Knowledge Repository”, which is updated every quarter.

Market Estimation: Market size estimations involved in-depth study of product features, technology updates, geographic presence, product demand, sales data (value or volume), historical year-on-year growth, and others. Other approaches were also utilized to derive market size and forecasts. Where no hard data was available, we employed modeling techniques in order to produce comprehensive datasets. A rigorous methodology has been adopted, wherein the available hard data are cross-referenced with the following data types to produce estimates:

Demographic Data: Healthcare expenditure, inflation rates, and others
Industry Indicators: R&D investment, technology stage, and infrastructure, sector growth, and facilities

Market Forecasting: Market forecasts for various segments are derived taking into account drivers, restraints/challenges, and opportunities prevailing in the market and considering advantages/disadvantages of segments/sub-segments over other segments/sub-segments. Business environment, historical sales pattern, unmet needs, competitive intensity, and country-wise surgery data are some of the other pivotal factors, which are considered to derive market forecasts.

レポート目次

1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Wound Irrigation Systems Market
4. Market Overview
4.1. Introduction
4.1.1. Segment Definition
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Wound Irrigation Systems Market Analysis and Forecast, 2017–2031
4.4.1. Market Revenue Projections (US$ Mn)
5. Key Insights
5.1. Technological advancements
5.2. Regulatory scenario by Region/Globally
5.3. Key Industry Events (mergers, acquisitions, partnerships, etc.)
5.4. COVID-19 Pandemic Impact on Industry (value chain and short / mid / long term impact)
6. Global Wound Irrigation Systems Market Analysis and Forecasts, by Product Type
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast, by Product Type, 2017–2031
6.3.1. Wetting Agents
6.3.2. Topical Antibiotics
6.3.3. Antiseptics
6.3.4. Irrigation Fluids
6.4. Market Attractiveness Analysis, by Product Type
7. Global Wound Irrigation Systems Market Analysis and Forecast, by Wound Type
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast, by Wound Type, 2017–2031
7.3.1. Burns
7.3.2. Diabetic Foot Ulcers
7.3.3. Surgical Wounds
7.3.4. Traumatic Wounds
7.3.5. Others
7.4. Market Attractiveness Analysis, by Wound Type
8. Global Wound Irrigation Systems Market Analysis and Forecast, by End-user
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Market Value Forecast, by End-user, 2017–2031
8.3.1. Hospitals
8.3.2. Ambulatory Surgery Centers
8.3.3. Home Care
8.3.4. Others
8.4. Market Attractiveness Analysis, by End-user
9. Global Wound Irrigation Systems Market Analysis and Forecast, by Region
9.1. Key Findings
9.2. Market Value Forecast, by Region
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Market Attractiveness Analysis, by Country/Region
10. North America Wound Irrigation Systems Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast, by Product Type, 2017–2031
10.2.1. Wetting Agents
10.2.2. Topical Antibiotics
10.2.3. Antiseptics
10.2.4. Irrigation Fluids
10.3. Market Value Forecast, by Wound Type, 2017–2031
10.3.1. Burns
10.3.2. Diabetic Foot Ulcers
10.3.3. Surgical Wounds
10.3.4. Traumatic Wounds
10.3.5. Others
10.4. Market Value Forecast, by End-user, 2017–2031
10.4.1. Hospitals
10.4.2. Ambulatory Surgery Centers
10.4.3. Home Care
10.4.4. Others
10.5. Market Value Forecast, by Country, 2017–2031
10.5.1. U.S.
10.5.2. Canada
10.6. Market Attractiveness Analysis
10.6.1. By Product Type
10.6.2. By Wound Type
10.6.3. By End-user
10.6.4. By Country
11. Europe Wound Irrigation Systems Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Product Type, 2017–2031
11.2.1. Wetting Agents
11.2.2. Topical Antibiotics
11.2.3. Antiseptics
11.2.4. Irrigation Fluids
11.3. Market Value Forecast, by Wound Type, 2017–2031
11.3.1. Burns
11.3.2. Diabetic Foot Ulcers
11.3.3. Surgical Wounds
11.3.4. Traumatic Wounds
11.3.5. Others
11.4. Market Value Forecast, by End-user, 2017–2031
11.4.1. Hospitals
11.4.2. Ambulatory Surgery Centers
11.4.3. Home Care
11.4.4. Others
11.5. Market Value Forecast, by Country/Sub-region, 2017–2031
11.5.1. Germany
11.5.2. U.K.
11.5.3. France
11.5.4. Spain
11.5.5. Italy
11.5.6. Rest of Europe
11.6. Market Attractiveness Analysis
11.6.1. By Product Type
11.6.2. By Wound Type
11.6.3. By End-user
11.6.4. By Country/Sub-region
12. Asia Pacific Wound Irrigation Systems Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Product Type, 2017–2031
12.2.1. Wetting Agents
12.2.2. Topical Antibiotics
12.2.3. Antiseptics
12.2.4. Irrigation Fluids
12.3. Market Value Forecast, by Wound Type, 2017–2031
12.3.1. Burns
12.3.2. Diabetic Foot Ulcers
12.3.3. Surgical Wounds
12.3.4. Traumatic Wounds
12.3.5. Others
12.4. Market Value Forecast, by End-user, 2017–2031
12.4.1. Hospitals
12.4.2. Ambulatory Surgery Centers
12.4.3. Home Care
12.4.4. Others
12.5. Market Value Forecast, by Country/Sub-region, 2017–2031
12.5.1. China
12.5.2. Japan
12.5.3. India
12.5.4. Australia & New Zealand
12.5.5. Rest of Asia Pacific
12.6. Market Attractiveness Analysis
12.6.1. By Product Type
12.6.2. By Wound Type
12.6.3. By End-user
12.6.4. By Country/Sub-region
13. Latin America Wound Irrigation Systems Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Product Type, 2017–2031
13.2.1. Wetting Agents
13.2.2. Topical Antibiotics
13.2.3. Antiseptics
13.2.4. Irrigation Fluids
13.3. Market Value Forecast, by Wound Type, 2017–2031
13.3.1. Burns
13.3.2. Diabetic Foot Ulcers
13.3.3. Surgical Wounds
13.3.4. Traumatic Wounds
13.3.5. Others
13.4. Market Value Forecast, by End-user, 2017–2031
13.4.1. Hospitals
13.4.2. Ambulatory Surgery Centers
13.4.3. Home Care
13.4.4. Others
13.5. Market Value Forecast, by Country/Sub-region, 2017–2031
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Rest of Latin America
13.6. Market Attractiveness Analysis
13.6.1. By Product Type
13.6.2. By Wound Type
13.6.3. By End-user
13.6.4. By Country/Sub-region
14. Middle East & Africa Wound Irrigation Systems Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast, by Product Type, 2017–2031
14.2.1. Wetting Agents
14.2.2. Topical Antibiotics
14.2.3. Antiseptics
14.2.4. Irrigation Fluids
14.3. Market Value Forecast, by Wound Type, 2017–2031
14.3.1. Burns
14.3.2. Diabetic Foot Ulcers
14.3.3. Surgical Wounds
14.3.4. Traumatic Wounds
14.3.5. Others
14.4. Market Value Forecast, by End-user, 2017–2031
14.4.1. Hospitals
14.4.2. Ambulatory Surgery Centers
14.4.3. Home Care
14.4.4. Others
14.5. Market Value Forecast, by Country/Sub-region, 2017–2031
14.5.1. GCC Countries
14.5.2. South Africa
14.5.3. Rest of Middle East & Africa
14.6. Market Attractiveness Analysis
14.6.1. By Product Type
14.6.2. By Wound Type
14.6.3. By End-user
14.6.4. By Country/Sub-region
15. Competition Landscape
15.1. Market Player – Competition Matrix (by tier and size of companies)
15.2. Market Share Analysis, by Company, 2021
15.3. Company Profiles
15.3.1. Stryker
15.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.1.2. Product Portfolio
15.3.1.3. Financial Overview
15.3.1.4. SWOT Analysis
15.3.1.5. Strategic Overview
15.3.2. B Braun
15.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.2.2. Product Portfolio
15.3.2.3. Financial Overview
15.3.2.4. SWOT Analysis
15.3.2.5. Strategic Overview
15.3.3. Cardinal Health
15.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.3.2. Product Portfolio
15.3.3.3. Financial Overview
15.3.3.4. SWOT Analysis
15.3.3.5. Strategic Overview
15.3.4. Baxter
15.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.4.2. Product Portfolio
15.3.4.3. Financial Overview
15.3.4.4. SWOT Analysis
15.3.3.5. Strategic Overview
15.3.5. Zimmer Biomet
15.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.5.2. Product Portfolio
15.3.5.3. Financial Overview
15.3.5.4. SWOT Analysis
15.3.5.5. Strategic Overview
15.3.6. Becton, Dickinson and Company
15.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.6.2. Product Portfolio
15.3.6.3. Financial Overview
15.3.6.4. SWOT Analysis
15.3.6.5. Strategic Overview
15.3.7. Schulke
15.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.7.2. Product Portfolio
15.3.7.3. Financial Overview
15.3.7.4. SWOT Analysis
15.3.7.5. Strategic Overview
15.3.8. Bionix
15.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.8.2. Product Portfolio
15.3.8.3. Financial Overview
15.3.8.4. SWOT Analysis
15.3.8.5. Strategic Overview
15.3.9. Cooper surgical
15.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.9.2. Product Portfolio
15.3.9.3. Financial Overview
15.3.9.4. SWOT Analysis
15.3.9.5. Strategic Overview
15.3.10. Sanara MedTech
15.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.10.2. Product Portfolio
15.3.10.3. Financial Overview
15.3.10.4. SWOT Analysis
15.3.10.5. Strategic Overview
15.3.11. Mölnlycke Health Care AB
15.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.11.2. Product Portfolio
15.3.11.3. Financial Overview
15.3.11.4. SWOT Analysis
15.3.11.5. Strategic Overview
15.3.12. Irrisept
15.3.12.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.12.2. Product Portfolio
15.3.12.3. Financial Overview
15.3.12.4. SWOT Analysis
15.3.12.5. Strategic Overview
15.3.13. Actimaris
15.3.13.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.13.2. Product Portfolio
15.3.13.3. Financial Overview
15.3.13.4. SWOT Analysis
15.3.13.5. Strategic Overview
15.3.14. Pulsecare medical
15.3.14.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.14.2. Product Portfolio
15.3.14.3. Financial Overview
15.3.14.4. SWOT Analysis
15.3.14.5. Strategic Overview

List of Tables

Table 01: Global Wound Irrigation Systems Market Value (US$ Mn) Forecast, by Product Type 2017–2031

Table 02: Global Wound Irrigation Systems Market Value (US$ Mn) Forecast, by Wound Type 2017–2031

Table 03: Global Wound Irrigation Systems Market Value (US$ Mn) Forecast, by End-user, 2017‒2031

Table 04: Global Wound Irrigation Systems Market Value (US$ Mn) Forecast, by Region, 2017–2031

Table 05: North America Wound Irrigation Systems Market Value (US$ Mn) Forecast, by Country, 2017–2031

Table 06: North America Wound Irrigation Systems Market Value (US$ Mn) Forecast, by Product Type 2017–2031

Table 07: North America Wound Irrigation Systems Market Value (US$ Mn) Forecast, by Wound Type 2017–2031

Table 08: North America Wound Irrigation Systems Market Value (US$ Mn) Forecast, by End-user, 2017‒2031

Table 09: Europe Wound Irrigation Systems Market Value (US$ Mn) Forecast, by Country/Sub-Region, 2017–2031

Table 10: Europe Wound Irrigation Systems Market Value (US$ Mn) Forecast, by Product Type 2017–2031

Table 11: Europe Wound Irrigation Systems Market Value (US$ Mn) Forecast, by Wound Type 2017–2031

Table 12: Europe Wound Irrigation Systems Market Value (US$ Mn) Forecast, by End-user, 2017‒2031

Table 13: Asia Pacific Wound Irrigation Systems Market Value (US$ Mn) Forecast, by Country/Sub-Region, 2017–2031

Table 14: Asia Pacific Wound Irrigation Systems Market Value (US$ Mn) Forecast, by Product Type 2017–2031

Table 15: Asia Pacific Wound Irrigation Systems Market Value (US$ Mn) Forecast, by Wound Type 2017–2031

Table 16: Asia Pacific Wound Irrigation Systems Market Value (US$ Mn) Forecast, by End-user, 2017‒2031

Table 17: Latin America Wound Irrigation Systems Market Value (US$ Mn) Forecast, by Country/Sub-Region, 2017–2031

Table 18: Latin America Wound Irrigation Systems Market Value (US$ Mn) Forecast, by Product Type 2017–2031

Table 19: Latin America Wound Irrigation Systems Market Value (US$ Mn) Forecast, by Wound Type 2017–2031

Table 20: Latin America Wound Irrigation Systems Market Value (US$ Mn) Forecast, by End-user, 2017‒2031

Table 21: Middle East & Africa Wound Irrigation Systems Market Value (US$ Mn) Forecast, by Country/Sub-Region, 2017–2031

Table 22: Middle East & Africa Wound Irrigation Systems Market Value (US$ Mn) Forecast, by Product Type 2017–2031

Table 23: Middle East & Africa Wound Irrigation Systems Market Value (US$ Mn) Forecast, by Wound Type 2017–2031

Table 24: Middle East & Africa Wound Irrigation Systems Market Value (US$ Mn) Forecast, by End-user, 2017‒2031